These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. In vitro release of betamethasone dipropionate from petrolatum-based ointments. Zatz JL; Varsano J; Shah VP Pharm Dev Technol; 1996 Oct; 1(3):293-8. PubMed ID: 9552312 [TBL] [Abstract][Full Text] [Related]
46. Influence of different test parameters on in vitro drug release from topical diclofenac formulations in a vertical diffusion cell setup. Klein S Pharmazie; 2013 Jul; 68(7):565-71. PubMed ID: 23923638 [TBL] [Abstract][Full Text] [Related]
47. Assessment of value and applications of in vitro testing of topical dermatological drug products. Flynn GL; Shah VP; Tenjarla SN; Corbo M; DeMagistris D; Feldman TG; Franz TJ; Miran DR; Pearce DM; Sequeira JA; Swarbrick J; Wang JC; Yacobi A; Zatz JL Pharm Res; 1999 Sep; 16(9):1325-30. PubMed ID: 10496646 [TBL] [Abstract][Full Text] [Related]
48. A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone. Wen Y; Ban J; Mo Z; Zhang Y; An P; Liu L; Xie Q; Du Y; Xie B; Zhan X; Tan L; Chen Y; Lu Z Nanotechnology; 2018 Oct; 29(42):425101. PubMed ID: 30074486 [TBL] [Abstract][Full Text] [Related]
50. Use of gelatin-acacia coacervate containing benzocaine in topical formulations. Ichwan AM; Karimi M; Dash AK J Pharm Sci; 1999 Aug; 88(8):763-6. PubMed ID: 10430539 [TBL] [Abstract][Full Text] [Related]
51. Continuous manufacturing of a pharmaceutical cream: Investigating continuous powder dispersing and residence time distribution (RTD). Bostijn N; Van Renterghem J; Vanbillemont B; Dhondt W; Vervaet C; De Beer T Eur J Pharm Sci; 2019 Apr; 132():106-117. PubMed ID: 30831193 [TBL] [Abstract][Full Text] [Related]
52. Rheological properties of three different vitamin D ointments and their clinical perception by patients with mild to moderate psoriasis. Marty JP; Lafforgue C; Grossiord JL; Soto P J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():7-10. PubMed ID: 16274405 [TBL] [Abstract][Full Text] [Related]
53. Oxygen diffusion coefficients in commonly used topical semisolid creams. Wang JC; Ju LK; Ho CS Pharm Res; 1988 Feb; 5(2):92-8. PubMed ID: 3247298 [TBL] [Abstract][Full Text] [Related]
54. Characterization of starch Pickering emulsions for potential applications in topical formulations. Marku D; Wahlgren M; Rayner M; Sjöö M; Timgren A Int J Pharm; 2012 May; 428(1-2):1-7. PubMed ID: 22366058 [TBL] [Abstract][Full Text] [Related]
55. Effect of ointment bases on topical and transdermal delivery of salicylic acid in rats: evaluation by skin microdialysis. Murakami T; Yoshioka M; Okamoto I; Yumoto R; Higashi Y; Okahara K; Yata N J Pharm Pharmacol; 1998 Jan; 50(1):55-61. PubMed ID: 9504435 [TBL] [Abstract][Full Text] [Related]
56. Analysis of the nitrogen mustard mechlorethamine in topical pharmaceutical preparations by high-performance liquid chromatography. Reepmeyer JC J Chromatogr A; 2005 Sep; 1085(2):262-9. PubMed ID: 16106707 [TBL] [Abstract][Full Text] [Related]
57. In situ-forming hydrogels for sustained ophthalmic drug delivery. Nanjawade BK; Manvi FV; Manjappa AS J Control Release; 2007 Sep; 122(2):119-34. PubMed ID: 17719120 [TBL] [Abstract][Full Text] [Related]
58. Drug release from semisolid dosage forms: a comparison of two testing methods. Petró É; Paál TL; Erős I; Kenneth AS; Baki G; Csóka I Pharm Dev Technol; 2015 May; 20(3):330-6. PubMed ID: 24328512 [TBL] [Abstract][Full Text] [Related]
59. [Effects of Manufacturing Conditions on Pharmaceutical Properties of Petrolatum Ointment]. Ashizuka Y; Horisawa E Yakugaku Zasshi; 2016 Aug; 136(8):1161-9. PubMed ID: 27193304 [TBL] [Abstract][Full Text] [Related]
60. Development of a Topical 48-H Release Formulation as an Anti-scarring Treatment for Deep Partial-Thickness Burns. Dorati R; Medina JL; DeLuca PP; Leung KP AAPS PharmSciTech; 2018 Jul; 19(5):2264-2275. PubMed ID: 29790019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]